Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative study on chemical characteristics of aromatic volatile organic compounds (VOCs) and gene expression in scented and non-scented <i>Rosa Hybrida</i> cultivars.

Physiology and molecular biology of plants : an international journal of functional plant biology·2025
Same author

Evaluation of changes in mean choroidal thickness before and after treatment with steroids and laser photocoagulation in patients with Eales' disease.

International journal of retina and vitreous·2025
Same author

Endogenous Aspergillus endophthalmitis complicated by florid retinal neovascularization: double trouble.

Retinal cases & brief reports·2025
Same author

The complete congenital retino-cephalo-facial vascular malformation (Wyburn-Mason) syndrome.

Eye (London, England)·2025
Same author

Quantitative automated pupillometry in diabetic patients and correlation with retinal nerve fibre layer thickness.

Eye (London, England)·2025
Same author

Pinpointing prime structural attributes of potential MMP-2 inhibitors comprising alkyl/arylsulfonyl pyrrolidine scaffold: a ligand-based molecular modelling approach validated by molecular dynamics simulation analysis.

SAR and QSAR in environmental research·2024

Related Experiment Video

Updated: May 31, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Inflammatory glaucoma.

Sonam A Bodh1, Vasu Kumar, Usha K Raina

  • 1Department of Ophthalmology, Guru Nanak Eye Center, Maulana Azad Medical College, New Delhi - 110 001, India.

Oman Journal of Ophthalmology
|June 30, 2011
PubMed
Summary
This summary is machine-generated.

Uveitis can cause glaucoma through various mechanisms, impacting aqueous humor outflow. Differentiating uveitic glaucoma from steroid-induced glaucoma requires careful patient history and follow-up.

Keywords:
Intraocular pressureglaucomainflammationuveitis

More Related Videos

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
06:35

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres

Published on: February 2, 2015

Related Experiment Videos

Last Updated: May 31, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
06:35

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres

Published on: February 2, 2015

Area of Science:

  • Ophthalmology
  • Immunology

Background:

  • Glaucoma is a significant complication of uveitis, affecting approximately 20% of patients.
  • Anterior uveitis, a common form, can present acutely or chronically, leading to secondary glaucoma.

Purpose of the Study:

  • To review the mechanisms of glaucoma development in uveitis patients.
  • To discuss diagnostic challenges and treatment strategies for uveitic glaucoma.

Main Methods:

  • Literature search conducted on the Medline database via PubMed interface.
  • Review of studies focusing on uveitis, iridocyclitis, and glaucoma.

Main Results:

  • Iridocyclitis obstructs aqueous outflow via acute inflammatory processes or chronic scarring.
  • Steroid-induced glaucoma must be differentiated from uveitic glaucoma through clinical evaluation.
  • Glaucoma medications may have unpredictable effects on intraocular pressure in uveitis.

Conclusions:

  • Effective management of uveitic glaucoma requires understanding its multifaceted mechanisms.
  • Treatment involves anti-inflammatory agents and antiglaucoma drugs, with surgery reserved for medical failures.
  • Distinguishing between uveitic and steroid-induced glaucoma is crucial for appropriate therapeutic decisions.